166 related articles for article (PubMed ID: 31753927)
1. Cryptic insertions of the immunoglobulin light chain enhancer region near
Fuster C; Martín-Garcia D; Balagué O; Navarro A; Nadeu F; Costa D; Prieto M; Salaverria I; Espinet B; Rivas-Delgado A; Terol MJ; Giné E; Forcada P; Ashton-Key M; Puente XS; Swerdlow SH; Beà S; Campo E
Haematologica; 2020 Aug; 105(8):e408-e411. PubMed ID: 31753927
[No Abstract] [Full Text] [Related]
2.
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
[TBL] [Abstract][Full Text] [Related]
3. Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14.
Aventín A; Nomdedéu J; Briones J; Espinosa I; Bordes R; Sierra J
J Clin Pathol; 2003 Oct; 56(10):798-800. PubMed ID: 14514791
[TBL] [Abstract][Full Text] [Related]
4. t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.
Iaccarino I; Afify L; Aukema SM; Reddemann K; Schütt P; Flür M; Klapper W
Haematologica; 2018 Sep; 103(9):e432-e435. PubMed ID: 29773591
[No Abstract] [Full Text] [Related]
5. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1-negative mantle cell lymphoma.
Seto M
Blood; 2013 Feb; 121(8):1249-50. PubMed ID: 23429984
[TBL] [Abstract][Full Text] [Related]
7. CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
Shiller SM; Zieske A; Holmes H; Feldman AL; Law ME; Saad R
Cancer Genet; 2011 Mar; 204(3):162-4. PubMed ID: 21504716
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
[TBL] [Abstract][Full Text] [Related]
9. SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?
Simonsen AT; Schou M; Sørensen CD; Bentzen HH; Nyvold CG
Leuk Lymphoma; 2015; 56(9):2724-7. PubMed ID: 25629991
[No Abstract] [Full Text] [Related]
10. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Mantle Cell Lymphoma Isolated to the Testis After 19-Year Remission: A Case Report and Review of the Literature.
Liu C; Baine MJ; Fisher KW; Armitage JO; Enke CA
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e125-e129. PubMed ID: 36572584
[No Abstract] [Full Text] [Related]
12. Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing.
Polonis K; Schultz MJ; Olteanu H; Smadbeck JB; Johnson SH; Vasmatzis G; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB; Peterson JF
Ann Diagn Pathol; 2020 Jun; 46():151533. PubMed ID: 32408254
[TBL] [Abstract][Full Text] [Related]
13. SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis.
Meggendorfer M; Kern W; Haferlach C; Haferlach T; Schnittger S
Leukemia; 2013 Dec; 27(12):2388-91. PubMed ID: 23648671
[No Abstract] [Full Text] [Related]
14. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
15. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.
Murga Penas EM; Callet-Bauchu E; Ye H; Gazzo S; Berger F; Schilling G; Albert-Konetzny N; Vettorazzi E; Salles G; Wlodarska I; Du MQ; Bokemeyer C; Dierlamm J
Blood; 2010 Mar; 115(11):2214-9. PubMed ID: 19965626
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.
Lokvenc M; Kalinova M; Forsterova K; Klener P; Trneny M; Fronkova E; Kodet R
Ann Hematol; 2018 Mar; 97(3):467-474. PubMed ID: 29273915
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
[TBL] [Abstract][Full Text] [Related]
18. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
[TBL] [Abstract][Full Text] [Related]
19. The pathologic diagnosis of mantle cell lymphoma.
Li S; Xu J; You MJ
Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
[TBL] [Abstract][Full Text] [Related]
20. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
